Detall de la convocatòria
Característiques
Característica |
---|
Objectiu de la convocatòria
The focus of the call is on the initiation of multidisciplinary consortia working on (therapeutics of) malignant lymphoma, malignant lymphoid neoplasia and related malignant blood diseases (particularly lymphoid disorders). The grant will cover costs for the organization of an international meeting to initiate the consortium. |
Característiques principals
Evaluation criteria: 1. Clarity and pertinence of the objectives of the consortium; 2. Soundness of the concept; 3. Innovative potential; 4. Competence and experience of participating consortium partners. 1. Potential of the expected results for the future clinical applications including patients’ needs; 2. Industry and Patient Organization participation/engagement (when appropriate/applicable) |
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a: Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76. Marta López: mlopez4@imim.es Ext.: 1576 Carol Barnwell: cbarnwell@imim.es Ext.: 1670 |
Convocatòria (URL)
https://www.lymph-co.com/consortium-initiation-grant |
Informació addicional
Grant applications can be submitted continuously, |
Requisits
Applications from international research groups are welcomed but in particular proposals from scientific groups (national and/or international) with complementing expertise are appreciated. |
Dotació
Applications for funding for organization of the consortium initiation meeting have a maximum of € 15.000. Funding is a one-time support per consortium. |
Documentació
* Please note if your Head of Department is also your Supervisor, two letters should be written, one in each capacity. ** Please note that both letters of support must be in English, on headed paper and signed |
Arxius
Arxiu |
---|